No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ARKG ARK Genomic Revolution ETF
- 23.970
- +0.680+2.92%
Close May 1 16:00 ET
24.760High23.160Low
24.760High23.160Low5.56MVolume23.220Open23.290Pre Close133.09MTurnover9.85%Turnover Ratio--P/E (Static)56.50MShares38.97052wk High--P/B1.35BFloat Cap21.97052wk Low--Dividend TTM56.50MShs Float114.427Historical High--Div YieldTTM6.87%Amplitude14.604Historical Low23.916Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
10x Genomics First Quarter 2024 Earnings: In Line With Expectations
Maintained Buy Rating on Schrodinger: Navigating Short-Term Hurdles With Long-Term Catalysts in Sight
Schrodinger Inc (SDGR) Q1 2024 Earnings Call Transcript Highlights: A Mixed Start With ...
Earnings Call Summary | Schrodinger(SDGR.US) Q1 2024 Earnings Conference
The following is a summary of the Schrödinger, Inc. (SDGR) Q1 2024 Earnings Call Transcript:Financial Performance:Schrödinger reported Q1 revenue of $36.6 million, a decrease compared to Q1 2023's $
Insider Moves Spark Speculation: 10X Genomics Executives Rethink Stock Sale Strategies
Schrödinger, Inc. (SDGR) Q1 2024 Earnings Call Transcript
Schrödinger, Inc. (SDGR) Q1 2024 Earnings Call Transcript